Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic value of metabolic tumor volume on [18F]FDG PET/CT in addition to the TNM classification system of locally advanced non-small cell lung cancer.
Brose A, Miederer I, König J, Gkika E, Sahlmann J, Schimek-Jasch T, Schreckenberger M, Nestle U, Kappes J, Miederer M. Brose A, et al. Among authors: schimek jasch t. Cancer Imaging. 2024 Dec 21;24(1):171. doi: 10.1186/s40644-024-00811-7. Cancer Imaging. 2024. PMID: 39709461 Free PMC article. Clinical Trial.
Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial.
Gkika E, Dejonckheere CS, Sahlmann J, Barth SA, Schimek-Jasch T, Adebahr S, Hecht M, Miederer M, Brose A, Binder H, König J, Grosu AL, Nestle U, Rimner A. Gkika E, et al. Among authors: schimek jasch t. Radiother Oncol. 2024 Nov;200:110521. doi: 10.1016/j.radonc.2024.110521. Epub 2024 Sep 3. Radiother Oncol. 2024. PMID: 39236984 Clinical Trial.
Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113-08113 LungTech Phase II Trial Results.
Levy A, Adebahr S, Hurkmans C, Ahmed M, Ahmad S, Guckenberger M, Geets X, Lievens Y, Lambrecht M, Pourel N, Lewitzki V, Konopa K, Franks K, Dziadziuszko R, McDonald F, Fortpied C, Clementel E, Fournier B, Rizzo S, Fink C, Riesterer O, Peulen H, Andratschke N, McWilliam A, Gkika E, Schimek-Jasch T, Grosu AL, Le Pechoux C, Faivre-Finn C, Nestle U. Levy A, et al. Among authors: schimek jasch t. J Thorac Oncol. 2024 Sep;19(9):1297-1309. doi: 10.1016/j.jtho.2024.05.366. Epub 2024 May 22. J Thorac Oncol. 2024. PMID: 38788924 Clinical Trial.
Cardiac Function Modifies the Impact of Heart Base Dose on Survival: A Voxel-Wise Analysis of Patients With Lung Cancer From the PET-Plan Trial.
Craddock M, Nestle U, Koenig J, Schimek-Jasch T, Kremp S, Lenz S, Banfill K, Davey A, Price G, Salem A, Faivre-Finn C, van Herk M, McWilliam A. Craddock M, et al. Among authors: schimek jasch t. J Thorac Oncol. 2023 Jan;18(1):57-66. doi: 10.1016/j.jtho.2022.09.004. Epub 2022 Sep 18. J Thorac Oncol. 2023. PMID: 36130693 Free article. Clinical Trial.
Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG).
Martin D, Schreckenbach T, Ziegler P, Filmann N, Kalinauskaite G, Tinhofer I, Budach V, Gani C, Zips D, Schimek-Jasch T, Schäfer H, Grosu AL, Thomas E, Krause M, Dapper H, Combs S, Hoffmann C, Stuschke M, Walter F, Belka C, Kurth I, Hadiwikarta WW, Baumann M, Rödel C, Fokas E. Martin D, et al. Among authors: schimek jasch t. Radiother Oncol. 2022 Feb;167:233-238. doi: 10.1016/j.radonc.2021.12.050. Epub 2022 Jan 6. Radiother Oncol. 2022. PMID: 34999135
Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies.
Gkika E, Adebahr S, Brenner A, Schimek-Jasch T, Radicioni G, Exner JP, Rühle A, Spohn SKB, Popp I, Zamboglou C, Sprave T, Firat E, Niedermann G, Nicolay NH, Nestle U, Grosu AL, Duda DG. Gkika E, et al. Among authors: schimek jasch t. Cancers (Basel). 2021 Nov 16;13(22):5725. doi: 10.3390/cancers13225725. Cancers (Basel). 2021. PMID: 34830880 Free PMC article.
Impact of radiotherapy protocol adherence in NSCLC patients treated with concurrent chemoradiation: RTQA results of the PET-Plan trial.
Gkika E, Schimek-Jasch T, Kremp S, Lenz S, Stockinger M, Schaefer-Schuler A, Mix M, Küsters A, Tosch M, Hehr T, Eschmann SM, Bultel YP, Hass P, Fleckenstein J, Thieme AH, Dieckmann K, Miederer M, Holl G, Rischke HC, Adebahr S, König J, Binder H, Grosu AL, Nestle U. Gkika E, et al. Among authors: schimek jasch t. Radiother Oncol. 2021 Oct;163:32-38. doi: 10.1016/j.radonc.2021.07.017. Epub 2021 Jul 24. Radiother Oncol. 2021. PMID: 34311004 Clinical Trial.
Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial.
Gkika E, Lenz S, Schimek-Jasch T, Waller CF, Kremp S, Schaefer-Schuler A, Mix M, Küsters A, Tosch M, Hehr T, Eschmann SM, Bultel YP, Hass P, Fleckenstein J, Thieme AH, Stockinger M, Dieckmann K, Miederer M, Holl G, Rischke HC, Adebahr S, König J, Binder H, Grosu AL, Nestle U. Gkika E, et al. Among authors: schimek jasch t. Cancers (Basel). 2020 Nov 13;12(11):3359. doi: 10.3390/cancers12113359. Cancers (Basel). 2020. PMID: 33202825 Free PMC article.
31 results